Fernández-Murga, M.L.; Serrano-GarcÃa, L.; D’Auria, G.; Hernández, M.P.; MartÃnez-Priego, L.; Ferrús-Abad, L.; de Marco, G.; DomÃnguez-Márquez, M.V.; Llombart-Cussac, A.
Immunogenicity of SARS-CoV-2 mRNA Vaccine in Breast Cancer Patients Undergoing Active Treatment: A Prospective Observational Study. Pathogens 2025, 14, 947.
https://doi.org/10.3390/pathogens14090947
AMA Style
Fernández-Murga ML, Serrano-GarcÃa L, D’Auria G, Hernández MP, MartÃnez-Priego L, Ferrús-Abad L, de Marco G, DomÃnguez-Márquez MV, Llombart-Cussac A.
Immunogenicity of SARS-CoV-2 mRNA Vaccine in Breast Cancer Patients Undergoing Active Treatment: A Prospective Observational Study. Pathogens. 2025; 14(9):947.
https://doi.org/10.3390/pathogens14090947
Chicago/Turabian Style
Fernández-Murga, MarÃa Leonor, LucÃa Serrano-GarcÃa, Giuseppe D’Auria, MarÃa Portero Hernández, Llúcia MartÃnez-Priego, Loreto Ferrús-Abad, Griselda de Marco, MarÃa Victoria DomÃnguez-Márquez, and Antonio Llombart-Cussac.
2025. "Immunogenicity of SARS-CoV-2 mRNA Vaccine in Breast Cancer Patients Undergoing Active Treatment: A Prospective Observational Study" Pathogens 14, no. 9: 947.
https://doi.org/10.3390/pathogens14090947
APA Style
Fernández-Murga, M. L., Serrano-GarcÃa, L., D’Auria, G., Hernández, M. P., MartÃnez-Priego, L., Ferrús-Abad, L., de Marco, G., DomÃnguez-Márquez, M. V., & Llombart-Cussac, A.
(2025). Immunogenicity of SARS-CoV-2 mRNA Vaccine in Breast Cancer Patients Undergoing Active Treatment: A Prospective Observational Study. Pathogens, 14(9), 947.
https://doi.org/10.3390/pathogens14090947
